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Abstract: Selective treatment of the retinal pigment epithelium (RPE) by using short-pulse
lasers leads to a less destructive treatment for certain retinal diseases in contrast to conventional
photocoagulation. The introduction of selective retina therapy (SRT) to clinical routine is still
precluded by the challenges to reliably monitor treatment success and to automatically adjust
dose within the locally varying therapeutic window. Combining micrometer-scale depth resolving
capabilities of optical coherence tomography (OCT) with SRT can yield real-time information
on the laser-induced changes within the RPE after a laser pulse or even during treatment with
a laser pulse train. In the present study, SRT and OCT were combined to treat ex-vivo porcine
eyes demonstrating closed-loop dose-control. We found a reliable correlation of specific signal
changes in time resolved OCT images and physiological lesions in the RPE. First experiments,
including 23 porcine eyes, prove the feasibility of the novel treatment concept.
© 2018 Optical Society of America under the terms of the OSA Open Access Publishing Agreement
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1. Introduction
While already in the 1950s panretinal photocoagulation (PRP) using xenon arc lamps were
employed for sealing retinal breaks and treating tumors [1] the actual break-through of PRP only
occurred with the advent of lasers in the 1960s that allowed precise focusing of high energy
beams. Guided by slit-lamps, lasers reduced the spot-size on the retina from 2000 µm to 100 µm.
Increased focus ability and energy density allowed ophthalmologists to apply the treatment in
a much more precise way. These laser photocoagulation (LPC) techniques were shown to be
effective therapies for proliferative diabetic retinopathy [2] and advanced forms of nonproliferative
diabetic retinopathy associated with macular edema [3]. Later, LPC was also proposed for the
treatment of age related macular degeneration (AMD) and other macular diseases [4–7]. Today,
LPC still remains an established method for retinal diseases. Progress in real-time visualization
technologies like fundus cameras, confocal retinal laser scanners and even 3D-imaging like
optical coherence tomography further improve the procedure.
The underlying mode of action for photocoagulation relies on the thermal destruction of retinal
cells due to absorption of laser light directed through the eye. The rise in local temperature of
20°C to 30°C, by heating of the intracellular melanosome, causes denaturation of the heated
proteins and cauterizes vessels and the overlying photoreceptors by heat diffusion [8–10]. Due
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to the slow heating process and the strong heat dissipation into the surroundings, before local
temperature can rise, the use of long laser pulses (∼ms) or even continuous wave lasers risks to
destroy cells in all retinal layers and laterally neighbored regions, impairing healthy photoreceptor
(PR) cells [11, 12]. These adverse effects can lead to scotomata, reduced night vision, and
disruption of the retinal anatomy through scarring.
LPC’s ability to destroy tissue that does not directly absorb the radiation can be utilized
to deactivate unhealthy tissue such as tumors [13]. Furthermore, it was shown that LPC can
also be used to increase oxygen and nutrient supply to the inner retina, thus favorably altering
the hemodynamics [14,15]. Different hypotheses explaining this process have been developed,
including laser-disruption of tight junctions in the retinal pigment epithelium (RPE), increased
inward oxygen diffusion [16] and reduction of oxygen demand of outer retina layers followed
by increased oxygen and nutrient supply to the inner retina due to the destruction of energy-
demanding tissue [16–18]. As the RPE layer between retina and choroid is part of the blood-brain
barrier, it controls permeability between the photosensitive tissue of the retina and the nutrient-
and oxygen-rich choroid as well as the active transport through these regions [19, 20]. Like
other epithelia it also can completely regenerate through cellular proliferation after damage
from healthy regions, which is unique amongst all retinal layers [21, 22]. Restoration of the
RPE after laser treatment has been documented histologically, which may be explained by the
establishment of a new barrier of RPE cells and a subsequent re-activation of the RPE pump and
thus providing the RPE’s integrity [23, 24]. This has led to the development of a new form of
treatment that deposits energy primarily in the RPE, the so-called selective retina therapy (SRT).
SRT demonstrated successful treatment of central serous chorioretinopathy (CSC), diabetic
macular edema (DME) and AMD [25–30]. Selective treatment of the RPE layer is enabled by the
high melanin concentration within the ∼10 µm thick monolayer, which absorbs about 50% of
the incident radiation across a wide spectrum spanning from the UV to the near infrared [31].
During normal vision this enables the RPE to prevent diffuse scattering and multiple detection of
light by the more superficial photoreceptors, which would result in image blur [20, 32]. The only
regenerative PR-portion, the outer segments, interdigitate with the apical microvilli of the RPE,
which facilitates selective heating of the RPE.
An aging Bruch’s membrane (BM) has been identified as a potential cause for numerous
diseases and in fact might be the physiological target of the SRT treatment. Due to the lack of a
widely approved working mechanism for SRT, our working hypothesis is that selective destruction,
removal and regrowth or transplantation of the dysfunctional RPE-BM-choriocapillaris (CC)-
complex, which results in a local rejuvenation, builds the basis for treatment of multiple
diseases [33].
The performance of SRT relies on spatial and temporal confinement which reduces the energy
required to achieve the same result without affecting neighbored layers when the laser operates
with a pulse length shorter than the thermal relaxation time of the RPE of 10 µs [30]. During
this process, the structural integrity of RPE cells is destroyed by fast expanding and collapsing
microbubbles which are formed around laser heated intracellular pigments [34–36]. Although
the precise biological effects, especially caused by sub-lethal cellular irradiation, still need to be
evaluated clinically, it is certain that cell-wall rupture leads to cell death.
Since SRT ideally only affects the RPE, it is much less destructive than conventional
photocoagulation and leaves the original layered morphology intact. Henceforth proper control
of pulse energy and pulse duration is crucial to introduce therapeutically significant lesions
in the RPE to limit collateral damage by excess energy deposition [37–39]. Since absorption
properties vary significantly and non-predictively between eyes and even within the same eye
on cellular level [32, 40], it is impossible to set a static threshold value for the optimum pulse
energy that always fits the local therapeutic window. Ophthalmoscopically, lesions in the RPE are
invisible and in practice only detectable two hours after treatment through fundus fluorescence
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angiography (FFA) [31, 41]. As the perforations in the RPE leak blood through the locally
interrupted blood-brain barrier, FFA shows this bleeding on the retinal side of the RPE-CC-
complex and clearly demarks successfully treated RPE sites [42]. While very accurate, the long
delay between treatment and detection as well as side-effects evoked by the injected dye limit the
usefulness of FFA in medical routine and prevent practicable simultaneous monitoring of SRT
performance within a single session.
For real-time feedback on treatment success, several approaches are taking advantage of
microbubbles generation and also of the associated shock-wave that is emitted during their
expansion and collapse. Methods such as measuring the change in reflectivity at the bubble
surfacewith backscattered light have been implemented [43,44]. It was found that the backscattered
light changes as soon as microbubbles appear. First studies with chinchillas showed a good match
in general when comparing the signal difference of the emitted pulse and the backreflected light,
which is higher in the case of microbubbles, with the gold standard evaluation methods like
fluorescine angiography, fundus photography, OCT and histology. Another real-time dosimetry
approach uses the acoustic feedback to detect the appearance of microvapour bubbles [36,43,44].
During µs laser treatment, optoacoustic transients are induced at the RPE. The characteristic of
the acoustic signal strongly changes due to the fast volume change as soon as micro bubble grow
and collapse [45]. Therefore, this method needs calibration with low energy treatment pulses.
The complexity involved prohibited wide uptake of the technology and did not allow to establish
SRT as standard therapy for the above mentioned retinal diseases.
Here we describe the use of real-time optical coherence tomography (OCT) in parallel to SRT to
observe signal variations correlated to the creation of RPE lesions. OCT is a spectrally broadband,
depth resolving and successively cross-sectional imaging technique based on low-coherence
interferometry [46]. As a fast (∼10 kHz), non-invasive and non-contact technique it is already
well established for high-resolution optical recording of the three-dimensional reflectivity in long
term changes [46]. Modern OCT systems are able to resolve axial structures of typically 1 µm to
10 µm in-vivo and even systems with axial resolutions in the sub-micrometer range have been
reported [47].
With this method we follow up on [48] where effects of treatment laser pulses could be
indirectly detected as a change of intensity of the OCT depth-scans (A-scans), which correspond
to the local reflectivity of tissue. In a time-resolved sequence of A-scans, an M-scan (motion
mode), the change in the complex pattern is seen as an obvious interruption. While several groups
used OCT as imaging modality to compare layers before and after treatment [49, 50], or Doppler
OCT for thermal expansion measurements [51], Steiner et al. have been, to our knowledge, the
only ones using OCT for real-time SRT quantification of the direct shock-wave formation.
Pursuing their work, we show in this more extensive study, that the signal changes in OCT
M-scans during SRT allow precise real-time prediction of retinal lesions. In combination with
adaptive laser pulse energy, using SRT in ramp-mode, and a fast algorithm-based treatment stop,
OCT-SRT can provide a reliable dosimetry control during treatment.
2. Materials and methods
For this study, ex-vivo porcine eyes were collected at a local slaughterhouse, transported in
cooled saline solution and treated within three hours post-mortem. Out of 29 treated eyes
with 1421 treatment spots, 23 eyes and 1054 treatment spots were included. Six eyes and a
total of 367 treatment spots were excluded because an evaluation was not possible (mostly
because of damage of the RPE during the preparation for live/death staining). To maintain stable
physiological conditions, the cornea was regularly humidified during treatment. Our experimental
setup consisted of a medically approved commercial SRT treatment system (R:Gen; Lutronic,
Goyang, Republic of Korea) and an in-house built OCT system. The narrowband, multimode
treatment laser operated at 527 nm wavelength, 1.7 µs pulse length and with adjustable pulse
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energies between 13 µJ and 340 µJ. On the retina, a spot size of 160 µm was reached with a top
hat beam shape. A pulse train of 30 pulses at 100 Hz was shot during treatment. R:Gen’s "ramp
mode", which increased energy linearly from pulse to pulse with minimum energy set to 39.4 µJ
and maximum to 197 µJ (see Fig. 1 for illustrations), was used.
Fig. 1. In ramp mode the pulse energy increases from pulse to pulse within one pulse train.
By adjusting the trigger signal length, the number of pulses and thus the maximum applied
energy can be adjusted.
To alter the last applied pulse energy although the maximum energy Emax remained fixed, the
trigger signal length for the treatment laser was modified to fire either only the first pulse, the
first 4, 9, 14, 18, 23 or all 30 pulses (in which case Emax was reached). Previous work, in which
a pulse repetition rate of 100 Hz was used, has shown that each pulse within one burst can be
considered as standalone because no significant cumulative effects take place [52]. The seven
different burst lengths correspond to seven different classes and were evaluated as such, as can be
seen in Table 1. Low-power treatment positions on the RPE were hard to identify individually
under the microscope. A predefined pattern, as shown in Fig. 4(b), was marked using high energy
marker lesions. A scanhead using mirrors in two axes allowed directing the focus of both beams
simultaneously. The OCT system uses a broadband light source (Exalos, Switzerland) with a
central wavelength of λC = 800 nm, ∆λ = 120 nm of spectral bandwidth, a CCD line camera
(AVIIVA EM4, ev2, UK) with 2048 pixels as parts of an in-house developed spectrometer. An
overall sensitivity of ∼100 dB was achieved, which is sufficient to identify and track the retinal
layers of interest and is typical for commercial ophthalmic OCT devices. The beams of the
treatment laser and the OCT laser were aligned coaxially in free space using a dichroic 700 nm
long-pass mirror so that the OCT-scan contained the center of the therapeutic laser as shown
in Fig. 2. Eyes were treated at 49 different locations while OCT signals were recorded at an
amplitude mode scan (A-scan) rate of 50 kHz during each 300 ms long treatment cycle focused
on the RPE. A-scans were arranged sequentially to yield a time modulated, depth-resolved image
or M-scan [53].
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Fig. 2. Setup of the combined collinear SRT- and OCT system. BS: Beam splitter, with
75:25 ratio, where 75 % of incident light is conducted into the sample arm. Ref. Arm:
Reference arm, in free-space and with the possibility to change polarization via manual fiber
polarization controllers. To prevent polarization-caused transmission proprieties changes
in the dichroic mirror, identical polarization controllers are inserted into the sample arm.
L1 and L2 constitute the delivery optics that enable scanning and positioning of the laser
beam within the eye by using the scanhead. Le is the lens of the eye itself. Therapy laser
and OCT laser are focused on the retina. Reflected light is separated again by the dichroic
mirror. Interfering light (from sample and reference arm) covering the 120 nm bandwidth is
expanded by a spectrometer and finally analyzed by a CCD line cam.
2.1. Biological evaluation using live/dead staining
Immediately after treatment, eyes were cut open posterior to the lens in the coronal plane. The
vitreous body was removed, the upper retinal layers were peeled off, in order to have direct vision
on the RPE, that typically stays attached to the CC in the rigid part of the sample, containing the
sclera and choroid. The region of interest was cut out, resulting in a block of approximately 7 mm
× 7 mm with the thickness of the sclera and choroid. The LIVE/DEAD Viability/Cytotoxicity Kit
L3224 (Invitrogen, Paisley, UK) was used to mark living and dead cells, according to its protocol.
Evaluation took place utilizing a Zeiss Axio Lab.A1 (Zeiss, Germany) fluorescence microscope
with 470 nm excitation frequency and the Zeiss FS 56HE filters. Calceine, emitting at 517 nm
binds to living cells, which appeared green under the fluorescence microscope, while ethidium
homodimer can penetrate the cell wall of dead cells and binds to the DNA in the nuclei, which
then appeared as red dots (Fig. 3) [54]. Directly visible thermo-mechanical cellular damage and
short-term cell death until fixation was therefore defined as the pass-fail criterion. Long term
cellular or tissue changes and the differentiation between apoptosis and necrosis would require
live animal treatment or culturing of the enucleated eye, which was not the aim of the current
study.
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Fig. 3. Fluorescence microscope image of the scleral sample portion after peeling of the
inner retina, viewed from the retinal side. Cells were stained 5 hours post mortem. At sites of
treatment (Region a), the typically hexagonal arranged isoprismatic RPE cells disappeared
completely and single dead cells can be seen as red dots at lesion borders (Region c). Region
b shows healthy living cells.
2.2. Manual and automated M-scan signal washout detection
Evaluation of the recorded OCT M-scans took place post-treatment. Typical M-scans can be
seen in Fig. 4(a). The single most striking feature during laser exposure is a sudden drop in
OCT A-scan signal strength, where reflectivity information suddenly completely disappears. The
origin of this missing OCT-signal will be discussed below.
For every applied treatment location, the corresponding M-scan was analyzed for signal
washout. An M-scan was labeled positive in case of these visible signal washouts predicting a
lesion in the RPE layer. Conversely, no visible signal washout meant a negative label for the
M-scan, hence predicting no lesion. All M-scans were visually inspected by the investigators.
The investigator labeled each M-scan accordingly. Additionally, the algorithm described below
has been developed in order to detect these signal washouts in an automated manner, as it was
planned to be implemented for further studies or later in clinics. To establish the algorithm, the
results of the manual evaluation were used as the gold standard.
The first step of the algorithm was to detect the retinal pigment epithelium. This layer had the
highest intensity, hence the highest pixel values in the image. To detect the signal washouts, which
are characterized by vertical edges, a continuous Sobel-operator, as a standard edge detection
filter, was applied. After filtering, the pixel-values of each A-scan were added, scaled and stored
(X). To detect signal washout, the algorithm moved from left to right through the M-scan image
(compare Fig. 5). It compares the value X of the current A-scan with a current threshold value
(CTh). If X is above the threshold, a signal washout is detected and the A-scan was labeled as
positive, meaning it contained a signal washout. The threshold was not static because M-scan
appearance is changing from each recording to another, therefore the threshold was calculated
according to (1). The threshold is calculated using the 50 A-scans recorded immediately before
the current A-scan. The current mean value of the filter (X¯) is used to give the baseline of the
threshold while the current standard deviation (σn) and a sensitivity factor (κ) is used to adapt the
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filter to noise. In case of large noise, the standard deviation increases and therefore the threshold
gets higher to reduce the number of also positives.
CTh = X¯ + σn × κ (1)
X¯ =
1
50
n−1∑
n−50
X (2)
σn = σ({Xn−50, ..., Xn−1}) (3)
with:
CTh = current threshold
X = cumulative sum A-scan after edge detection
X¯ = current mean value of the filter
σn = current standard deviation
κ = sensitivity factor
The sensitivity factor value was trained on separate data to obtain the best fit with the gold
standard.
3. Results and discussion
3.1. Origin of the OCT signal washout and speckle variations
Obviously, the simplest assumption for explaining the temporary disappearance as due to a
suddenly diminished tissue reflectivity does not apply. Also, overexposure of the spectral filter
detector is not applicable because of the spectrally well separated excitation laser. Following the
model of a higher reflective gas-bubble, which is supported by direct reflectivity measurements,
the increase of reflected light can lead to saturation of the OCT’s sample arm signal, followed
by a lack of spectral modulation that is the carrier of depth information within the frequency
domain encoded reflectivity measurement. However, an increase of reflectivity and saturation of
the spectrum is not visible in the underlying spectra. As a third explanation rapid changes in the
spectral signal can cause fringe-washout in the time-integrating spectrally resolving OCT-sensor.
Especially the occurrence of a highly reflective bubble, but still with less than 8% of reflectivity
and a bent surface, can easily cast strong spectral oscillations on top of the much weaker signals
from the surrounding tissue. Due to the microsecond fast expansion of the bubble in the axial
resolution range the quickly changing signal would be time-integrated on the comparably slow
detector, which reduces its visibility due to destructive summation. The most viable explanation
for the signal loss is a fringe-washout caused by the mechanical vibrations due to rapid expansion
of the bubble. Fringe-washout requires a phase-shift larger than pi/2 or a physical shift of more
than half the carrier wavelength within a single acquisition and can be simulated by vibration
of tissue. To avoid this signal loss due to an acoustic shock-wave, OCT sampling frequencies
above 100 MHz or exposure times < 10 ns would be required. Sound waves in tissue travel at
more than 1000 m s−1 and the reflections from the rapidly shifted material (> 10 modulations
during a single A-scan acquisition time-window) within the depth-scan create the effect already
described above. Here however, the full depth-scan is suppressed, which perfectly corresponds to
the measurements.
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Fig. 4. a) M-scans from treatments using classic mode (all pulses with the same energy). The
red arrow indicates the pulse energy level, which increases from M-scan number 5 to M-scan
number 1. In the lowest energy M-scan (number 5) no apparent signal washout is visible
while the M-scan with highest pulse energy (number 1) shows distinct signal washouts. b)
Top view onto RPE layer under bright field microscope. The applied treatment pattern is
visible and allows for easy location of the treatment positions. Strong lesions, such as lesion
number 1, relate to strong signal washouts in the corresponding M-scan (M-scan number
1). Weak lesions (e.g., lesion number 4) conversely relate to weak M-scan signal washouts.
Spots with no visible lesion in the RPE layer (e.g., spot number 5) correlate to M-scans
without any signal washout.
Slower propagating effects, such as heat diffusion, were responsible for the temporal expansion
in signal washouts and shifts and speckle-changes that can be recognized in the M-scans. Clearly,
these effects were more pronounced for pulses with higher laser energies as depicted in Fig. 5(b).
This relationship could be exploited to relate the emerging signal washouts to the destruction
of RPE cells. Apparently, primarily cells that were destroyed by mechanical rupture due to
micro-bubble formation caused enough mechanical shift for the fringe washout. A minor portion
of false positives might be explained by the generation of a microbubble that was too small for
cell destruction, but strong enough to generate a shock-wave that influenced the OCT-scan. In the
following we empirically demonstrated this correlation.
3.2. Live/dead staining results
The LIVE/DEAD Viability/Cytotoxicity Kit L3224 confirmed that RPE and retinal cells were
still alive longer than five hours post-mortem. An example that demonstrated this behavior is
shown in Fig. 3, where most of the hexagonal RPE cells appeared in green when inking this
sample five hours post-mortem. This figure also confirms spatial selectivity of the treatment
within the RPE plane, as RPE cells appeared green in regions where no treatment took place
(Region b in Fig. 3), and dead cells were only found in border regions of a lesion. Often, there
were no RPE cells in the center of laser treatment spots because during treatment, microbubble
formation led to a rupture of the cell membrane and the cell content was washed away during
preparation. At locations where no laser treatment has been made, cells were found intact.
To exploit these findings, OCT M-scans have been used to predict the treatment outcome
within the biological tissue. Table 1 shows the results for the M-scan evaluation by an investigator,
while Table 2 show the results for the M-scan evaluation by the before described algorithm. Based
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Fig. 5. Signal washouts in M-scan caused by treatment in ramp-mode. a) Signal washout
(vertical black line) in M-scan induced by one single laser pulse with 54 µJ. b) Signal washout
induced by one single laser pulse with pulse energy of 180 µJ. The duration of the signal
washout in the upper retinal layers is longer than at the level of the RPE. Additionally, layers
in the middle are distorted for a longer time (∼4 ms).
on OCT M-scans, 795 treatment spots were correctly predicted by the manual evaluations, and
791 treatment spots by evaluation via algorithm (accuracy of 75 % in both cases).
The longer the chosen pulse burst, the more pulses were fired and the higher the pulse energy
of the last pulse. Therefore, the probability of cell destruction by microvapour bubble increased
resulting in a raise of predicted and detected lesions. With increasing treatment energy, the
observed signal washouts became intenser. For moderate energies signal washouts were restricted
to the RPE layer and spanned over one A-scan, as visible in Fig. 5(a). Higher energies gave rise
to more intense signal washouts, like in Fig. 5(b), spanning over multiple A-Scans and thus were
easier to identify. The results in Table 1 also indicate that lower treatment pulse energies can
reduce the accuracy because here some optically visible lesions showed no discernible signal
washout. Figure 6 shows examples of false positive and false negative results. The fluoroscopic
examination showed that relatively low treatment energies killed only a few cells in the laser focal
point. While these are apparently not sufficient to cause a detectable signal washout, it remains
open whether these cases are indeed misclassified because to our knowledge no study has shown
a minimum number of dead RPE cells necessary for a successful treatment.
Both evaluation methods were less sensitive for classes with low pulse numbers (class 1 and 4)
and less specific for classes with higher pulse numbers (class 23 and 30). In the classes 1 and
4, the number of true positives and false negatives to calculate the sensitivity is very small and
like-wise in classes 23 and 30, the numbers of true negatives and false positives to calculate the
specificity is again very small, yielding statistically questionable results.
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Table 1. Visual evaluation by an investigator. Results for the seven classes of different number
of laser pulses. All were acquired using the same ramp mode but with different number of
pulses.
Class (Number Pulses) 1 4 9 14 18 23 30 Overall
Energy of Last Pulse [µJ] 39 69 93 118 137 162 197
Number Evaluated Spots 151 153 151 150 153 145 151 1054
Signal Washouts in OCT 14 51 93 115 125 129 142 669
Lesions in RPE* 66 115 113 142 141 141 148 866
Correct Predictions 95 85 97 117 131 127 143 795
Accuracy** 0.63 0.56 0.64 0.78 0.86 0.88 0.95 0.75
Sensitivity 0.18 0.43 0.67 0.79 0.87 0.89 0.95 0.74
Specificity 0.98 0.95 0.55 0.63 0.75 0.25 0.67 0.84
* Seen under the fluorescence microscope
** Assuming the prevalence is correct, with a 95% confidence interval of [0.728, 0.780]
Table 2. Evaluation by algorithm. Results showed for the 7 classes with different number
of laser pulses. All were acquired using the same ramp mode but with different number of
pulses.
Class (Number Pulses) 1 4 9 14 18 23 30 Overall
Energy of Last Pulse [µJ] 39 69 93 118 137 162 197
Number Evaluated Spots 151 153 151 150 153 145 151 1054
Signal Washouts in OCT 36 58 97 121 129 132 140 713
Lesions in RPE* 66 115 113 142 141 141 148 866
Correct Predictions 93 74 99 121 131 132 141 791
Accuracy** 0.62 0.48 0.66 0.81 0.86 0.91 0.93 0.75
Sensitivity 0.33 0.41 0.70 0.82 0.88 0.92 0.94 0.76
Specificity 0.84 0.71 0.53 0.50 0.58 0.50 0.67 0.71
* Seen under the fluorescence microscope
** Assuming the prevalence is correct, with a 95% confidence interval of [0.728, 0.780]
Comparing the two tables, similar overall values for accuracy, sensitivity and specificity were
found for the evaluation by hand and the evaluation by algorithm, with slightly better values
for the findings by hand. In general the signal washout, as a predictor for RPE lesions, yields a
sensitivity of over 76% for the algorithm and 74% for the evaluation by hand. This means that
76% and 74%, respectively, of all lesions in the RPE layer were detected as such in the M-scan
evaluation. The achieved specificity was 84% and 71%, respectively. So, out of all spots treated
with laser energies too low for inducting lesions, 84% and 71%, were correctly predicted as
non-lesions based on M-scans as evaluated by the investigators and the algorithm, respectively.
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Fig. 6. This picture illustrates what is defined as false positive and false negative. Although
there is no lesion in b) at the position encircled in white, the M-scan in a) shows signal
washouts. In contrast, the M-scan in c) did not show any signal washout but the corresponding
region, marked with a white circle, in d) shows a clear damage in the RPE cell structure.
3.3. Opthalmologic treatment protocol
Based on our empirically established relationship between OCT signals and induced RPE lesions,
we propose to simultaneously monitor SRT by OCT. In particular, the application of the following
protocol will increase the reliability to obtain sufficient RPE lesions while remaining well below
the threshold for destruction of the entire retina. Starting with a value guaranteed to lie below the
photo-coagulation threshold, the laser’s pulse-energy is successively increased in the ramp mode.
An algorithm detects signal washouts as soon as they appear in the simultaneously acquired
M-scan and immediately stops the SRT laser (Fig. 7).
3.3.1. Proof of concept with manual dose control
We validated this procedure and the signal washout within OCT M-scans as predictor for
SRT success manually since our detection algorithm was not yet real-time capable. Here, the
investigator triggered single treatment pulses with increasing energy and checked for signal
washout directly after each shot. Once a washout was visible, the treatment at the current position
was stopped and the next target was treated. In the subsequent analysis as described above, the
treatment success at each location was assessed.
The pulse energies chosen for this protocol fit the pulse energies of a ramp mode with a
maximal energy of 197 µJ. This test has been repeated in two porcine eyes with a total of 58
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Fig. 7. Numbering on the horizontal-axis correspond to the laser pulse applied in ramp-mode
where the pulse events are indicated by white arrows. Signal washouts in the M-scan were
becoming more apparent with each pulse and thus with increasing pulse energy. On the
zoomed-out signal washouts, this effect is observable. During automated dose-control, the
first signal washout would be detected (in this case it is number 7) and the laser would stop
shooting, indicated by the red marker. Pulse 8 to 14 would not be fired.
included treatment spots. For every spot, there was an M-scan with a visible signal loss before 
the treatment was stopped. Under the microscope, 55 out of the 58 spots were identified as 
lesions and therefore as a successful treatment, which hence yields an accuracy of almost 95%. 
Exposures stopped at the threshold did not cause visual alterations of the morphology viewed 
from the retinal side. This very promising result makes us confident that following our proposed 
treatment protocol will indeed dependably control the necessary pulse energy for an optimal SRT 
of individual patients.
Conclusion
Findings from this study successfully demonstrate the potential of OCT utilization for an 
automated dose-control in SRT. It can be established as a safe method of treatment for retinal 
diseases by using its full potential with an optimum combination and interaction between 
treatment system and monitoring modality, including eye motion tracking and oﬄine treatment 
planning in a clinical environment.
Although this study has not yet implemented a complete automated system it has shown the 
proof of concept for a device where the ophthalmologist chooses the location of treatment and 
manually initiates a ramped sequence of pulses, similar to established solutions. Collinear coupled 
OCT acquired data would be processed in real time, and as soon as a first signal washout is 
detected, the treatment laser stops automatically at a dose significantly below the local, individual 
safety threshold. Latter can be preset by the clinician together with an absolute maximum value 
to avoid undesired photocoagulation. For optimal treatment the therapeutic window, defined as 
the ratio between the ophthalmologic and the angiographic ED50, can be set to a predefined 
value, such as 1.7 [19]. This intentionally pre-set overexposure would reduce the necessity for 
re-treatment, while keeping the collateral damage limited.
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We, and other groups as well, are certain that laser treatment is a very promising therapy for
retinal diseases in the future [55].
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